SG11201604763PA - Multilayered nanoparticle and methods of manufacturing and using the same - Google Patents

Multilayered nanoparticle and methods of manufacturing and using the same

Info

Publication number
SG11201604763PA
SG11201604763PA SG11201604763PA SG11201604763PA SG11201604763PA SG 11201604763P A SG11201604763P A SG 11201604763PA SG 11201604763P A SG11201604763P A SG 11201604763PA SG 11201604763P A SG11201604763P A SG 11201604763PA SG 11201604763P A SG11201604763P A SG 11201604763PA
Authority
SG
Singapore
Prior art keywords
manufacturing
methods
same
multilayered nanoparticle
multilayered
Prior art date
Application number
SG11201604763PA
Other languages
English (en)
Inventor
Subramanian Venkatraman
Tzee Ling Tina Wong
Bjorn Neu
Original Assignee
Univ Nanyang Tech
Singapore Health Serv Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nanyang Tech, Singapore Health Serv Pte Ltd filed Critical Univ Nanyang Tech
Publication of SG11201604763PA publication Critical patent/SG11201604763PA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
    • A61K48/0041—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid the non-active part being polymeric
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5052—Proteins, e.g. albumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111—General methods applicable to biologically active non-coding nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/30—Special therapeutic applications
    • C12N2320/32—Special delivery means, e.g. tissue-specific

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SG11201604763PA 2013-12-13 2014-12-09 Multilayered nanoparticle and methods of manufacturing and using the same SG11201604763PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361915790P 2013-12-13 2013-12-13
PCT/SG2014/000587 WO2015088445A1 (fr) 2013-12-13 2014-12-09 Nanoparticule multicouche et ses procédés de fabrication et d'utilisation

Publications (1)

Publication Number Publication Date
SG11201604763PA true SG11201604763PA (en) 2016-07-28

Family

ID=53371583

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201805073VA SG10201805073VA (en) 2013-12-13 2014-12-09 Multilayered nanoparticle and methods of manufacturing and using the same
SG11201604763PA SG11201604763PA (en) 2013-12-13 2014-12-09 Multilayered nanoparticle and methods of manufacturing and using the same

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG10201805073VA SG10201805073VA (en) 2013-12-13 2014-12-09 Multilayered nanoparticle and methods of manufacturing and using the same

Country Status (6)

Country Link
US (1) US10465189B2 (fr)
EP (1) EP3079705A4 (fr)
JP (1) JP2017500312A (fr)
CN (1) CN107073028A (fr)
SG (2) SG10201805073VA (fr)
WO (1) WO2015088445A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11672866B2 (en) 2016-01-08 2023-06-13 Paul N. DURFEE Osteotropic nanoparticles for prevention or treatment of bone metastases
AU2017378427A1 (en) 2016-12-14 2019-06-20 Ligandal, Inc. Methods and compositions for nucleic acid and protein payload delivery
US11357735B2 (en) 2017-02-01 2022-06-14 Centre National De La Recherche Scientifique Particles and compositions comprising the same for transfection
US11344629B2 (en) 2017-03-01 2022-05-31 Charles Jeffrey Brinker Active targeting of cells by monosized protocells
CN111032134B (zh) * 2017-06-30 2024-02-13 阿维塔斯有限公司 电喷雾导管
AU2018305148B2 (en) * 2017-07-26 2023-09-28 Albert-Ludwigs-Universität Freiburg Biodegradable multilayer nanocapsules for the delivery of biologically active agents in target cells
US11059016B2 (en) 2018-06-25 2021-07-13 Microsoft Technology Licensing, Llc Silica encapsulated DNA on magnetic nanoparticles
WO2021140509A1 (fr) * 2020-01-06 2021-07-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Supports de charges multiples de type microcapsule dans une microcapsule sensibles aux stimuli, leurs utilisations et des procédés pour leur préparation
EP4126030A1 (fr) * 2020-04-01 2023-02-08 University Of Florida Research Foundation, Incorporated Vaccin à nanoparticule d'arn multilamellaire contre le sars-cov-2
US20230183695A1 (en) * 2020-05-22 2023-06-15 Formulytica Pty Ltd. Compositions and methods for the delivery of agents to biological targets
US20230285296A1 (en) * 2020-07-24 2023-09-14 Nanyang Technological University Layer-by-layer coated nanoliposome for oral delivery of insulin
CN114376988B (zh) * 2022-01-20 2024-02-20 国家纳米科学中心 一种作用于有吞噬能力的细胞的核酸递送纳米载体及其制备方法与应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8440625B2 (en) * 2006-06-26 2013-05-14 University Of British Columbia Secreted protein acidic and rich in cysteine (SPARC) as chemotherapeutic sensitizers
WO2009058913A2 (fr) * 2007-10-29 2009-05-07 University Of Massachusetts Nanoparticules encapsulées pour l'administration d'acides nucléiques
US20120321573A1 (en) * 2009-10-02 2012-12-20 The General Hospital Corporation Compositions and methods of prophylaxis for contact dermatitis
EP2485739B1 (fr) 2009-10-09 2014-12-10 Singapore Health Services PTE. Ltd. Méthodes et compositions de modulation de cicatrisation de plaie fonctionnelle
EP2646059A4 (fr) * 2010-12-01 2016-07-27 Methodist Hospital System Polypeptides dégradables par une protéase et leurs utilisations
US9074187B2 (en) 2011-03-21 2015-07-07 Board Of Trustees Of The University Of Arkansas Nanostructural materials that increase mineralization in bone cells and affect gene expression through miRNA regulation and applications of same
KR101255149B1 (ko) 2011-10-14 2013-04-22 포항공과대학교 산학협력단 금속 나노 입자 기반 핵산 전달용 조성물 및 이의 제조방법
EP2841056A4 (fr) 2012-04-23 2015-09-16 Massachusetts Inst Technology Particules enrobées couche par couche stables

Also Published As

Publication number Publication date
EP3079705A1 (fr) 2016-10-19
JP2017500312A (ja) 2017-01-05
EP3079705A4 (fr) 2017-07-19
CN107073028A (zh) 2017-08-18
US10465189B2 (en) 2019-11-05
US20160319280A1 (en) 2016-11-03
WO2015088445A1 (fr) 2015-06-18
SG10201805073VA (en) 2018-07-30

Similar Documents

Publication Publication Date Title
HK1232243A1 (zh) 抗- 抗體及其用途
HK1223810A1 (zh) 製備吸收複合物的方法和採用其的吸收製品
TWI560787B (en) Interconnect structure and manufacturing method thereof
SG11201604763PA (en) Multilayered nanoparticle and methods of manufacturing and using the same
EP2969323A4 (fr) Articles gainés et procédés de fabrication de ceux-ci
PL3020845T3 (pl) Element wytłaczany na gorąco oraz sposób jego wytwarzania
EP2959299A4 (fr) Nanoparticules fluorescentes multicouches et leurs procédés de fabrication et d'utilisation
SG11201507640QA (en) Electromechanical device and method of fabricating the same
GB201306633D0 (en) Biaising circuitry and method thereof
EP2986452A4 (fr) Articles dispersibles et procédés de fabrication associés
EP2966042A4 (fr) Procédé de fabrication d'un stratifié de bismuth-vanadate et stratifié ainsi obtenu
SG11201508747XA (en) Tissue structure and manufacturing method therefor
EP2955021A4 (fr) Structure multicouche et son procédé de production
PL3074239T5 (pl) Korpus wielowarstwowy jako element zabezpieczający i sposób jego wytwarzania
EP2966186A4 (fr) Élément de renfort et son procédé de fabrication
HK1223736A1 (zh) 電池組件及其製造方法
TWI563628B (en) Semiconductor structure and method of fabricating the same
EP2946247A4 (fr) Film électrochromique solide comprenant des nanoparticules électrochromiques et ses procédés de formation faisant appel au dépôt couche par couche
EP3033801A4 (fr) Transition d'interconnexion et son procédé de fabrication
ZA201509283B (en) Dry formed filters and methods of making the same
PL3089850T3 (pl) Elementy kompozytowe i sposoby ich formowania
EP2963082A4 (fr) Corps à structure irrégulière et son procédé de fabrication
HK1219516A1 (zh) 層及其製造
SG10201400101VA (en) Photovoltaic device and method of manufacturing the same
TWI562414B (en) Magnetoresistive element and method of manufacturing the same